SCHEMBL3967415

SCHEMBL3967415

CC(C)(C(=O)Nc1cccc2ccccc12)S(=O)(=O)c1ccc(S(C)(=O)=O)cc1.COc1ccc(S(=O)(=O)C(C)(C)C(=O)Nc2cc(C(C)(C)C)no2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 1/20 0.42
BRAF P15056 1/20 0.42
KMT2A Q03164 5/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MAPK14 Q16539 3/20 0.42
CNR2 P34972 3/20 0.42
HCRTR1 O43613 1/20 0.41
HCRTR2 O43614 1/20 0.41
MEN1 O00255 4/20 0.40
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 3/20 0.40
HPGD P15428 1/20 0.40
MMP1 P03956 1/20 0.40
MMP9 P14780 1/20 0.40
MMP13 P45452 1/20 0.40
LMNA P02545 2/20 0.39
POLB P06746 1/20 0.39
NLRP3 Q96P20 1/20 0.39
CNR1 P21554 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1465888 0.85 CNR2 (0.56) RAF1MAPK14CNR2ALDH1A1CNR1
SCHEMBL12635879 0.84 KMT2A (0.58) KMT2ANPC1RAB9AMAPK14HCRTR1
SCHEMBL1465162 0.81 NLRP3 (0.52) KMT2ANPC1RAB9AMAPK14CNR2
SCHEMBL1464930 0.74 CNR2 (0.60) MAPK14CNR2ALDH1A1CNR1
SCHEMBL4072111 0.73 ALDH1A1 (0.44) KMT2ANPC1RAB9AMAPK14CNR2
SCHEMBL3964431 0.73 CNR2 (0.61) RAF1BRAFKMT2ARAB9ACNR2
SCHEMBL775376 0.73 CNR2 (0.58) MAPK14CNR2ALDH1A1CNR1
SCHEMBL1465550 0.73 CNR2 (0.67) MAPK14CNR2ALDH1A1CNR1
SCHEMBL1464184 0.72 MAPK14 (0.47) MAPK14CNR2ALDH1A1MMP1MMP9
SCHEMBL1464909 0.71 CNR2 (0.57) KMT2ACNR2MEN1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2081905-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2009-07-29 EP disclosed
WO-2008014199-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-01-31 WO disclosed